The Patent Finder

Terms ending in 2028

Allergan, Inc.

Every in-force patent on Allergan, Inc.'s record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 7,645,460Dosage Forms of Risedronate
In force
 · Medium confidence
Allergan Pharmaceuticals International LimitedIn forceMedium confidence
US 7,977,351Heteroaryl Dihydroindolones as Kinase Inhibitors
In force
 · High confidence
Allergan, Inc.In forceHigh confidence
US 8,236,023Apparatus and Method for Volume Adjustment of Intragastric Balloons
In force
 · High confidence
Boston Scientific Scimed, Inc.In forceHigh confidence
US 7,612,082Prostaglandin EP4 Antagonists
In force
 · High confidence
Allergan, Inc.In forceHigh confidence
US 9,365,485Substituted Arylcyclopentenes as Therapeutic Agents
In force
 · High confidence
Allergan, Inc.In forceHigh confidence
US 9,796,696Substituted Arylcyclopentenes as Therapeutic Agents
In force
 · High confidence
Allergan, Inc.In forceHigh confidence
US 7,884,115Compositions Comprising Nb-Dnj, Ne-Dnj or D-Glucaro-Delta-Lactam and Their Uses for the Treatment of Pain and Other Neurological Condittions
In force
 · High confidence
Allergan, Inc.In forceHigh confidence
US 8,039,496Therapeutic Compounds
In force
 · Medium confidence
Allergan, Inc.In forceMedium confidence
US 9,326,877Apparatus and method for intragastric balloon with in situ adjustment means
In force
 · High confidence
Boston Scientific Scimed, Inc.In forceHigh confidence
US 7,960,381Substituted Gamma Lactams as Therapeutic Agents
In force
 · Medium confidence
Allergan, Inc.In forceMedium confidence
67 more term ends in 2028 · Pro
10 of 77 patents shown. Soonest term end first, then patent number.
Pro members see all 77, including 48 expiring within the 18 months from Nov 22, 2026.
Upgrade to Pro
60 of these are in force and held by Allergan, Inc..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited